The objective of this study was to understand PSA testing patterns for older prostate cancer patients during the three years prior to their PCa diagnosis, and whether receipt of screening PSA testing was associated with distant stage disease at diagnosis. The gene discussed is KLK3; the disease is posterior cortical atrophy.